Two-year outcomes of intravitreal ziv-aflibercept.

Ahmad M MansourMohammed AshrafAbdulrazzak CharbajiMuhammad H YounisAhmed A R SoukaAvantika DograHana A MansourJay Chhablaninull null

Published in: The British journal of ophthalmology (2018)

IVZ appears safe and efficacious in the therapy of macular diseases through 2 years.

Keyphrases